Hanson Bryan C

SEC source: 0001524349-26-000008 · wk-form4_1788466256.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 67,261 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs are fully vested.

F2 · derivative.expiration_date: The RSUs are fully vested.

SEC source: 0001524349-26-000008 · wk-form4_1788466256.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,515

SEC source: 0001524349-26-000008 · wk-form4_1788466256.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211,983

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

SEC source: 0001524349-26-000005 · wk-form4_1778875715.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,316

Underlying: Common Stock · 34,315 shares

Expires 2034-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date.

SEC source: 0001524349-26-000005 · wk-form4_1778875715.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,722

SEC source: 0001524349-26-000005 · wk-form4_1778875715.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001524349-26-000002 · wk-form4_1773100090.xml · derivative · entry 4

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,816

Underlying: Common Stock · 31,907 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date.

F2 · derivative.expiration_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date.

SEC source: 0001524349-26-000002 · wk-form4_1773100090.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,910

SEC source: 0001524349-26-000002 · wk-form4_1773100090.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,305

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001524349-26-000002 · wk-form4_1773100090.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,963

Underlying: Common Stock · 105,963 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date.

F2 · derivative.expiration_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date.

SEC source: 0001964738-25-000080 · wk-form4_1756831788.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,261

Underlying: Common Stock · 67,261 shares

Expires 2033-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.

F3 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of the first through third anniversary of the grant date, subject to continued service through the vesting date.

SEC source: 0001964738-25-000080 · wk-form4_1756831788.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,398

SEC source: 0001964738-25-000080 · wk-form4_1756831788.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects vesting of Solventum RSUs received upon conversion of previously granted 3M RSUs. Each 3M RSU converted into the number of Solventum RSUs equal to the number of 3M Shares subject to such 3M RSU Award immediately prior to the Effective Time of the separation, multiplied by the SpinCo Ratio as set forth in the Employee Matters Agreement entered into in connection with the separation.

SEC source: 0001618921-25-000088 · wk-form4_1755295875.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,655

F1 · kind: Annual share grant issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan in arrears with respect to services rendered over the course of the prior year.

SEC source: 0001628280-25-025968 · wk-form4_1747340599.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,631

Underlying: Common Stock · 34,315 shares

Expires 2034-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date.

SEC source: 0001628280-25-025968 · wk-form4_1747340599.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,605

SEC source: 0001628280-25-025968 · wk-form4_1747340599.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,108

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-011722 · wk-form4_1741639194.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,723

Underlying: Common Stock · 95,723 shares

Expires 2035-03-06

F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date.

SEC source: 0001618921-24-000118 · wk-form4_1730857441.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,835

F1 · kind: Shares issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder).

SEC source: 0001127602-24-023494 · form4.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,522

Underlying: Common Stock · 67,261 shares

Expires 2033-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.

F3 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of the first through third anniversary of the grant date, subject to continued service through the vesting date.

SEC source: 0001127602-24-023494 · form4.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,793

SEC source: 0001127602-24-023494 · form4.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,261

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects vesting of Solventum RSUs received upon conversion of previously granted 3M RSUs. Each 3M RSU converted into the number of Solventum RSUs equal to the number of 3M Shares subject to such 3M RSU Award immediately prior to the Effective Time of the separation, multiplied by the SpinCo Ratio as set forth in the Employee Matters Agreement entered into in connection with the separation.

SEC source: 0001127602-24-015503 · form4.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,946

Underlying: Common Stock · 102,946 shares

Expires 2034-05-13

F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.

F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date.

SEC source: 0001618921-23-000084 · wk-form4_1699052582.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,694

F1 · kind: Shares issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder).

SEC source: 0001127602-23-023744 · form4.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Group Pres & CEO Health Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,754

Underlying: Common Stock · 126,754 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of 3M common stock.

F2 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning September 1, 2023.

F2 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning September 1, 2023.

SEC source: 0001062993-23-006287 · form4.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,625

Underlying: Common Stock · 47,625 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

SEC source: 0001062993-23-004629 · form4.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,132 shares

Expires 2023-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F1 · shares: This number of restricted stock units ("RSU's") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

SEC source: 0001062993-23-004629 · form4.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,797

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.

SEC source: 0001062993-23-004629 · form4.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,549

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This number of restricted stock units ("RSU's") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

F2 · balance_after: Includes 194 shares acquired under the Company's Employee Stock Purchase Plan June 30, 2022.

SEC source: 0001062993-22-006627 · form4.xml · derivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,524

Underlying: Common Stock · 26,524 shares

Expires 2024-02-25

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed.

F2 · derivative.underlying_shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed.

F2 · balance_after: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed.

SEC source: 0001062993-22-006627 · form4.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,680

Underlying: Common Stock · 14,680 shares

Expires 2023-02-21

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed.

F2 · derivative.underlying_shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed.

F2 · balance_after: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed.

SEC source: 0001062993-22-005356 · form4.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,819

Underlying: Common Stock · 166,819 shares

Expires 2032-02-18

F1 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing on February 18, 2023.

SEC source: 0001062993-21-013313 · form4.xml · derivative · entry 6

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 32,950 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of Company common stock.

F4 · shares: On December 19, 2017, the reporting person was granted 49,425 PRSUs, which were to be earned if and to the extent certain stock price performance goals were achieved by December 19, 2021. The Company's compensation committee determined that, based on actual stock price performance, 32,950 PRSUs were earned and vested on December 19, 2021. The remaining 16,475 PRSUs were forfeited.

F4 · derivative.exercise_date: On December 19, 2017, the reporting person was granted 49,425 PRSUs, which were to be earned if and to the extent certain stock price performance goals were achieved by December 19, 2021. The Company's compensation committee determined that, based on actual stock price performance, 32,950 PRSUs were earned and vested on December 19, 2021. The remaining 16,475 PRSUs were forfeited.

F4 · derivative.expiration_date: On December 19, 2017, the reporting person was granted 49,425 PRSUs, which were to be earned if and to the extent certain stock price performance goals were achieved by December 19, 2021. The Company's compensation committee determined that, based on actual stock price performance, 32,950 PRSUs were earned and vested on December 19, 2021. The remaining 16,475 PRSUs were forfeited.

SEC source: 0001062993-21-013313 · form4.xml · derivative · entry 5

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,520 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of Company common stock.

F1 · shares: On December 19, 2017, the reporting person was granted 38,280 performance restricted stock units ("PRSUs"), which were to be earned if and to the extent certain stock price performance goals were achieved by December 19, 2021. The Company's compensation committee determined that, based on actual stock price performance, 25,520 PRSUs were earned and vested on December 19, 2021. The remaining 12,760 PRSUs were forfeited.

F1 · derivative.exercise_date: On December 19, 2017, the reporting person was granted 38,280 performance restricted stock units ("PRSUs"), which were to be earned if and to the extent certain stock price performance goals were achieved by December 19, 2021. The Company's compensation committee determined that, based on actual stock price performance, 25,520 PRSUs were earned and vested on December 19, 2021. The remaining 12,760 PRSUs were forfeited.

F1 · derivative.expiration_date: On December 19, 2017, the reporting person was granted 38,280 performance restricted stock units ("PRSUs"), which were to be earned if and to the extent certain stock price performance goals were achieved by December 19, 2021. The Company's compensation committee determined that, based on actual stock price performance, 25,520 PRSUs were earned and vested on December 19, 2021. The remaining 12,760 PRSUs were forfeited.

SEC source: 0001062993-21-013313 · form4.xml · nonDerivative · entry 4

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,223

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of PRSUs.

SEC source: 0001062993-21-013313 · form4.xml · nonDerivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,493

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: On December 19, 2017, the reporting person was granted 49,425 PRSUs, which were to be earned if and to the extent certain stock price performance goals were achieved by December 19, 2021. The Company's compensation committee determined that, based on actual stock price performance, 32,950 PRSUs were earned and vested on December 19, 2021. The remaining 16,475 PRSUs were forfeited.

SEC source: 0001062993-21-013313 · form4.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,543

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of PRSUs.

SEC source: 0001062993-21-013313 · form4.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,369

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On December 19, 2017, the reporting person was granted 38,280 performance restricted stock units ("PRSUs"), which were to be earned if and to the extent certain stock price performance goals were achieved by December 19, 2021. The Company's compensation committee determined that, based on actual stock price performance, 25,520 PRSUs were earned and vested on December 19, 2021. The remaining 12,760 PRSUs were forfeited.

F2 · balance_after: Includes 163 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on June 30, 2021.

SEC source: 0001062993-21-002184 · form4.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,866 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: Earned RSUs vested on February 26, 2021.

F4 · derivative.expiration_date: Earned RSUs vested on February 26, 2021.

SEC source: 0001062993-21-002184 · form4.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,686

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-21-002184 · form4.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,271

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 209 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan on January 9, 2021.

SEC source: 0001062993-21-002091 · form4.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,698

Underlying: Common Stock · 131,698 shares

Expires 2031-02-25

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 25, 2022.

SEC source: 0001062993-21-001859 · form4.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,866

Underlying: Common Stock · 1,866 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 1,866 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on February 26, 2021.

F3 · derivative.expiration_date: Earned RSUs will vest on February 26, 2021.

F2 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 1,866 RSUs.

F2 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 1,866 RSUs.

SEC source: 0001062993-20-006507 · form4.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: 8,625 of the RSUs vested on each of December 19, 2018, December 19, 2019 and December 19, 2020.

F3 · derivative.expiration_date: 8,625 of the RSUs vested on each of December 19, 2018, December 19, 2019 and December 19, 2020.

SEC source: 0001062993-20-006507 · form4.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,196

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSU").

SEC source: 0001062993-20-006507 · form4.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,193

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-20-000109 · edgar.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,568

SEC source: 0000911916-20-000072 · edgar.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,056 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: Earned RSUs vested on March 20, 2020.

F3 · derivative.expiration_date: Earned RSUs vested on March 20, 2020.

SEC source: 0000911916-20-000072 · edgar.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,568

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0000911916-20-000072 · edgar.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,156

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.